Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

COVID-19 increases age- and sex-controlled 21-day fatality rates for patients with melanoma, hematologic malignancies, uterine cancer, or kidney cancer

View ORCID ProfileHaiquan Li, Edwin Baldwin, Xiang Zhang, Colleen Kenost, Wenting Luo, Elizabeth A. Calhoun, Lingling An, Charles L. Bennett, Yves A. Lussier
doi: https://doi.org/10.1101/2021.02.06.21251099
Haiquan Li
1Department of Biosystems Engineering, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Haiquan Li
  • For correspondence: haiquan@arizona.edu bennettc@cop.sc.edu yves@arizona.edu
Edwin Baldwin
1Department of Biosystems Engineering, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiang Zhang
1Department of Biosystems Engineering, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Colleen Kenost
4Cancer Center and Department of Medicine, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenting Luo
1Department of Biosystems Engineering, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Calhoun
2Department of Population Health, University of Kansas Medical Center, Westwood, Kansas
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lingling An
1Department of Biosystems Engineering, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles L. Bennett
3Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, South Carolina
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: haiquan@arizona.edu bennettc@cop.sc.edu yves@arizona.edu
Yves A. Lussier
4Cancer Center and Department of Medicine, University of Arizona, Tucson, Arizona
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: haiquan@arizona.edu bennettc@cop.sc.edu yves@arizona.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article Information

doi 
https://doi.org/10.1101/2021.02.06.21251099
History 
  • February 8, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Haiquan Li, PhD+,*,1,
  2. Edwin Baldwin, BS+,1,
  3. Xiang Zhang, MS1,
  4. Colleen Kenost, EdD, MPH4,
  5. Wenting Luo, MS1,
  6. Elizabeth A. Calhoun, PhD2,
  7. Lingling An, PhD1,
  8. Charles L. Bennett, MD, PhD*,3 and
  9. Yves A. Lussier, MD*,4
  1. 1Department of Biosystems Engineering, University of Arizona, Tucson, Arizona
  2. 2Department of Population Health, University of Kansas Medical Center, Westwood, Kansas
  3. 3Department of Clinical Pharmacy and Outcomes Sciences, University of South Carolina, Columbia, South Carolina
  4. 4Cancer Center and Department of Medicine, University of Arizona, Tucson, Arizona
  1. ↵*Corresponding authors Correspondence should be addressed to: Haiquan Li haiquan{at}arizona.edu, Biosystems Engineering, The University of Arizona 1177 E 4th St., Tucson, Arizona 85721, Phone: (520) 621-1890, Charles L. Bennett bennettc{at}cop.sc.edu, Clinical Pharmacy and Outcomes Sciences, University of South Carolina, 715 Sumter Street, Columbia, SC 29208, Phone: (803) 777-9004, Yves A. Lussier yves{at}arizona.edu, University of Arizona Health Sciences, 1657 E. Helen St., Tucson, Arizona 85721, Phone: (520) 626-3968
  1. ↵+ equally contributed

Back to top
PreviousNext
Posted February 08, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
COVID-19 increases age- and sex-controlled 21-day fatality rates for patients with melanoma, hematologic malignancies, uterine cancer, or kidney cancer
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
COVID-19 increases age- and sex-controlled 21-day fatality rates for patients with melanoma, hematologic malignancies, uterine cancer, or kidney cancer
Haiquan Li, Edwin Baldwin, Xiang Zhang, Colleen Kenost, Wenting Luo, Elizabeth A. Calhoun, Lingling An, Charles L. Bennett, Yves A. Lussier
medRxiv 2021.02.06.21251099; doi: https://doi.org/10.1101/2021.02.06.21251099
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
COVID-19 increases age- and sex-controlled 21-day fatality rates for patients with melanoma, hematologic malignancies, uterine cancer, or kidney cancer
Haiquan Li, Edwin Baldwin, Xiang Zhang, Colleen Kenost, Wenting Luo, Elizabeth A. Calhoun, Lingling An, Charles L. Bennett, Yves A. Lussier
medRxiv 2021.02.06.21251099; doi: https://doi.org/10.1101/2021.02.06.21251099

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)